Total Count 119

JAMJOOM PHARMA - Latest News

27/07/2025
Jamjoom Pharma reviews 2025-2027 guidance
Argaam Special
24/07/2025
Jamjoom Pharma ups profit margin forecast to 33%: CEO
Argaam Special
24/07/2025
Jamjoom Pharma to distribute 20% dividend for H1 2025
Argaam
15/07/2025
Jamjoom Pharma plans to release Q2 2025 financials on July 24
Argaam
14/07/2025
Morgan Stanley 'market maker' for 40 TASI, Nomu firms
Argaam
07/07/2025
GIB Capital issues Q2 2025 earnings forecasts for Saudi companies
Argaam
06/07/2025
Q2 2025 earnings preview: AlJazira Capital
Argaam Special
06/07/2025
United Securities issues Q2 2025 earnings forecast
Argaam
03/07/2025
Al Rajhi Capital issues earnings estimates for Q2 2025
Argaam
01/07/2025
Jamjoom Pharma reappoints Mahmoud Jamjoom as Chairman
Argaam
26/06/2025
Jamjoom Pharma shareholders reject LTIP, buyback plan
Argaam
26/05/2025
Ranked: Tadawul's 50 most profitable companies in Q1 2025
Argaam Special
14/05/2025
How did analysts view Jamjoom Pharma Q1 2025 financials?
Argaam Special
14/05/2025
Jamjoom Pharma board proposes 100,000 share buyback
Argaam
12/05/2025
Jamjoom Pharma provides SAR 16.6M guarantee for Algeria JV loan
Argaam
05/05/2025
Ubhar Capital: Jamjoom Pharma Q1 profit above estimates, TP unchanged
Argaam
01/05/2025
Jamjoom Pharma’s profit grows on focus on high-margin therapeutic segments
Argaam Special
30/04/2025
Jamjoom Pharma revises guidance for next 3 years 
Argaam Special
29/04/2025
AlJazira Capital initiates coverage on Saudi pharmaceuticals sector, sets ratings
Argaam
21/04/2025
Highest-paid executives, board members of Saudi-listed firms in 2024
Argaam Special
20/04/2025
Jamjoom Pharma to disclose Q1 2025 results on April 30
Argaam
14/04/2025
Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms
Argaam
14/04/2025
GIB Capital issues Q1 2025 earnings estimates
Argaam
10/04/2025
SNB Capital sets Q1 2025 earnings estimates
Argaam
06/04/2025
United Securities issues Q1 2025 earnings forecast
Argaam Special
08/03/2025
Al Rajhi Capital sets Jamjoom Pharma rating, TP
Argaam
06/03/2025
Jamjoom Pharma sales rise 19% in Saudi Arabia, eyes expansion: CEO
Argaam Special
26/02/2025
Jamjoom Pharma 2024 revenue growth reflects operational improvements: CEO
Argaam
25/02/2025
Jamjoom Pharma to distribute 14.6% dividend for H2 2024
Argaam
11/02/2025
Jamjoom Pharma provides SAR 27.1M guarantee to JV in Algeria
Argaam
02/02/2025
Jamjoom Pharma provides SAR 17.7M guarantee for Algeria joint venture
Argaam
30/01/2025
Jamjoom Pharma Q4 2024: What are analysts predicting?
Argaam Special
25/01/2025
Ubhar Capital initiates coverage of Jamjoom Pharma, sets rating, TP
Argaam
12/01/2025
SNB Capital sets Q4 2024 earnings estimates
Argaam Special
12/01/2025
Osool & Bakheet previews Q4 2024 earnings estimates
Argaam Special
09/01/2025
United Securities issues Q4 2024 earnings forecasts
Argaam
06/01/2025
GIB Capital issues Q4 2024 earnings estimates
Argaam
02/01/2025
Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms
Argaam Special
01/01/2025
SNB Capital forecasts Tadawul earnings to rise 8% in 2025
Argaam
23/12/2024
Analyst ratings, average TP for Jamjoom Pharma post-Q3 2024
Argaam Special
27/10/2024
Jamjoom Pharma maintains 2024 guidance
Argaam Special
24/10/2024
What do analysts expect from Jamjoom Pharma's Q3 2024 results?
Argaam Special
10/10/2024
Jamjoom Pharma plans to disclose Q3 2024 financials on Oct. 27
Argaam
10/10/2024
GIB Capital's forecast on Q3 2024 earnings
Argaam Special
08/10/2024
Osool & Bakheet previews Q3 2024 earnings estimates
Argaam Special
07/10/2024
Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms
Argaam
06/10/2024
United Securities: As earnings loom, what to expect in Q3 2024?
Argaam
06/10/2024
Key events forecast to impact Saudi-listed firms’ earnings in Q3 2024
Argaam Special
15/09/2024
SNB Capital initiates coverage on Jamjoom Pharma, sets TP
Argaam
11/09/2024
How analysts rated Jamjoom Pharma after Q2 results?
Argaam Special
09/09/2024
Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital
ِArgaam
24/08/2024
FTSE Russell announces periodic changes to Saudi market
Argaam
15/08/2024
Here is a look at stocks, funds with ex-dates today
Argaam Special
12/08/2024
United Securities says Jamjoom Pharma’s net profit beats expectations
Argaam
12/08/2024
Jamjoom Pharma focuses on portfolio optimization, ups forecast for H2 growth: CEO
Argaam Special
06/08/2024
Jamjoom Pharma board plans 16% cash dividend for H1 2024
Argaam
05/08/2024
Analyst forecasts on Jamjoom Pharma Q2 2024 profit
Argaam Special
18/07/2024
Jamjoom Pharma to disclose Q2 2024 financials on Aug. 6
Argaam
16/07/2024
United Securities issues Q2 earnings estimates
Argaam
09/07/2024
Osool & Bakheet issues Q2 2024 earnings forecast
Argaam
08/07/2024
Jamjoom Pharma provides corporate guarantee to Algeria JV
Argaam
07/07/2024
GIB Capital previews Q2 2024 earnings
Argaam
04/07/2024
Al Rajhi Capital issues Q2 2024 profit forecasts
Argaam
04/07/2024
Key events likely to impact Saudi-listed firms’ earnings in Q2 2024
Argaam Special
05/06/2024
Jamjoom Pharma shareholders approve 15% dividend for H2 2023
Argaam
04/06/2024
Tadawul: Bahri, Jamjoom Pharma go ex-dividend today
Argaam Special
19/05/2024
United Securities sets rating, TP for Jamjoom Pharma
Argaam
14/05/2024
Jamjoom Pharma shareholders to vote on 15% dividend for H2 2023 on June 4
Argaam
13/05/2024
Jamjoom Pharma boosts presence in key markets, ramp up production: CEO
Argaam Special
21/04/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special
20/04/2024
Osool & Bakheet issues Q1 2024 earnings forecast
Argaam
16/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special
14/04/2024
GIB Capital previews Q1 2024 earnings
Argaam
06/04/2024
Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms
Argaam
04/04/2024
Jamjoom Pharma board proposes 15% dividend for H2 2023
Argaam
27/03/2024
Jamjoom Pharma's 2023 net profit exceeds estimates: United Securities
Argaam
25/03/2024
Jamjoom Pharma expects up to 15% revenue growth over next 2 years, plans expansion
Argaam
19/03/2024
Jamjoom Pharma to disclose 2023 financials on March 25
Argaam
20/02/2024
Jamjoom Pharma seen to post profit growth in Q4 2023
Argaam Special
30/01/2024
Jamjoom Pharma signs contract with LCGPA to localize drug production
Argaam
29/01/2024
LCGPA signs 4 agreements to localize pharma industry
Argaam
28/01/2024
Jamjoom Pharma gets SFDA approval to register eye drop facility in Jeddah
Argaam
21/01/2024
Jamjoom Pharma provides SAR 17.7M corporate guarantee to Algeria JV
Argaam
10/01/2024
GIB Capital previews Q4 2023 earnings
Argaam Special
10/01/2024
Jamjoom Pharma to participate in 42nd JP Morgan Healthcare Conference
Argaam
09/01/2024
How did analysts view TASI performance, top picks for 2024?
Argaam Special
08/01/2024
Al Rajhi Capital issues Q4 2023 earnings forecasts
Argaam Special
07/01/2024
United Securities previews Q4 2023 earnings for Saudi firms
Argaam Special
07/01/2024
Al Rajhi Capital expects TASI to hit 12,647 pts, names top picks
Argaam
19/12/2023
Trading ban on Jamjoom Pharma’s major shareholders ends today
Argaam
05/12/2023
How did analysts view Jamjoom Pharma’s Q3 financials?
Argaam Special
03/12/2023
GIB Capital sets rating for Jamjoom Pharma
Argaam
23/11/2023
Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP
Argaam
22/11/2023
Jamjoom Pharma offers SAR 18.5M corporate guarantee for Algeria JV
Argaam
15/11/2023
MSCI adds 1 fund, 2 firms to Small Cap Index
Argaam
01/11/2023
Jamjoom Pharma to disclose 9M 2023 results on Nov. 7
Argaam
05/10/2023
Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies
Argaam Special
30/09/2023
TASI leaps 5.5% in 9M 2023; Etihad Atheeb, Elm top gainers
ِArgaam special
25/09/2023
Tadawul announces indices maintenance for Q3 2023
Argaam
10/08/2023
Jamjoom Pharma revises up 2023 guidance
Argaam Special

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2025, Argaam Investment, All Rights Reserved
Call Request